Associate Professor Tropical Medicine


Shunmay Yeung is a paediatrician and has a background in health economics and operational research. She is the lead investigator for PACES (Proactive Case Detection and Community Particiation for the elimination of drug resistant malaria study) in Cambodia, as part of the Tracking Resistance to Artemisinins Collaboriation (TRAC).  She is also the LSHTM PI for PERFORM study, an ambitious European-wide Horizon 2020 project co-ordinated by Prof Mike Levin of Imperial College exploring the use of new diagnostic technologies for differentiating bacterial from viral infections in children . Previously she was deputy director and a core scientist for the ACT consortium.   She co-leads the Centre for Maternal, Adolescent, Reproductive and Child Health - Child Theme, and is active clinically as a consultant in Paediatric Infectious Disease at St Mary's Imperial College Hospital, London.  

She did her clinical training in London and has worked as a government medical officer in a district hospital in rural KwaZulu/Natal in South Africa where she also undertook clinical research on HIV in children.  In October 2014 she was one of the first LSHTM Ebola crisis volunteers, deploying with Save the Children to Sierra Leone where she helped with the setting up of the new Ebola Treatment Centre in Kerrytown.  She is now collaborating in a retrospective study examinining the factors affecting clinical outcomes in children admitted to holding centres and isolation units during the epidemic. 

Her PhD was on antimalarial drug resistance and drug policy and was undertaken in Southeast Asia, under the supervision of Professors Nicholas White and Anne Mills, with funding from the Wellcome Trust.  It employed economic and epidemiological modeling and field studies on the access to malaria diagnosis and treatment.  She continues to call upon this experience to help bridge between research, policy and practice.  

She maintains a strong affiliation with the Mahidol-Oxford Research Unit in Bangkok and was the co-ordinator for the Artemisinin  Resistance Confirmation, Characterization and Containment (ARC3) consortium.  She has worked for the WHO Global Malaria Programme and sits on a number of expert committees and advisory boards.   




Shunmay was the Module Organiser for the Distance Learning module on Control of Communicable Disease and supervises MSc  (mainly TMIH and CID) and PhD students.  She lectures on in-house modules including Applied Communicable Disease control module and AIDS module,  and also externally and takes an active role in teaching and mentoring.


Recent projects include mixed methods evaluations of Village Malaria Workers and of the private sector roll-out of subsidised malaria rapid diagnostic tests in Cambodia; mapping of artemisinin resistance and mobile and migrant populations in SE Asia; cost-effectiveness modelling of 8-aminoquonolones for the radical cure of P. vivax; methodological development in surveys of antimalarial quality; and analysis of the content of the "drug cocktails" commonly used to treat fevers in SE Asia. 

As a core scientist for the ACT consortium (http://www.actconsortium.org/) she supported individual projects and supports the on-going cross-cutting work especially in relation to non-malarial febrile illness, health economics and drug quality. 

Research areas

  • Child health
  • Clinical care
  • Clinical guidelines
  • Complex interventions
  • Diagnostics
  • Disease control
  • Drug resistance
  • Economic evaluation
  • Evaluation
  • Global Health
  • Health outcomes
  • Implementation research
  • Infectious disease policy
  • Medicines
  • Migration
  • Mixed methods
  • Modelling
  • Neonatal health
  • Private sector
  • Public health
  • Research : policy relationship


  • Economics
  • Epidemiology
  • Medicine
  • Operational research
  • Social Sciences

Disease and Health Conditions

  • Emerging Infectious Disease
  • Infectious disease
  • Malaria
  • Neglected Tropical Diseases (NTDs)
  • Pandemic diseases
  • Sepsis
  • Tropical diseases


  • East Asia & Pacific (developing only)
  • South Asia
  • Sub-Saharan Africa (all income levels)


  • Bangladesh
  • Bhutan
  • Cambodia
  • Indonesia
  • Lao PDR
  • Myanmar
  • Nigeria
  • Sierra Leone
  • Thailand
  • Uganda
  • United Kingdom

Other interests

  • Access To Care
  • Access To Medicines
  • Adherence
  • Africa
  • Antimalarial Drug Resistance
  • Artemisinin Resistance
  • Bacterial Infections
  • Child Survival
  • Clinical Tropical Medicine
  • Community Health Volunteers
  • Community Health Workers
  • Cost Effectiveness Analysis
  • Developing countries
  • Diagnostics,
  • Dried Blood Spots
  • Drug Access
  • Drug Quality
  • Ebola Virus Disease
  • Effectiveness Evaluations
  • Emerging Infectious Diseases
  • Health Economics
  • Malaria Centre
  • Paediatrics
  • Southeast Asia
  • clinical epidemiology
  • cost effectiveness
  • global health
  • social determinants of health
Back to top